Fude Yang

677 total citations · 1 hit paper
28 papers, 391 citations indexed

About

Fude Yang is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Pharmacology. According to data from OpenAlex, Fude Yang has authored 28 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 10 papers in Biological Psychiatry and 7 papers in Pharmacology. Recurrent topics in Fude Yang's work include Bipolar Disorder and Treatment (10 papers), Tryptophan and brain disorders (10 papers) and Schizophrenia research and treatment (10 papers). Fude Yang is often cited by papers focused on Bipolar Disorder and Treatment (10 papers), Tryptophan and brain disorders (10 papers) and Schizophrenia research and treatment (10 papers). Fude Yang collaborates with scholars based in China, United States and Estonia. Fude Yang's co-authors include Zhiren Wang, Min Liu, Jue Liu, Yongqian Wang, Weidong Wu, Qi Zhang, Yaogang Wang, Yaping Wang, Yubing Zhu and Tianmei Si and has published in prestigious journals such as PLoS ONE, Journal of Ethnopharmacology and Journal of Affective Disorders.

In The Last Decade

Fude Yang

26 papers receiving 381 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The associations of socioeconomic status, social activities, and loneliness with depressive symptoms in adults aged 50 years and older across 24 countries: findings from five prospective cohort studies

2024 35 citations Yaping Wang, Min Liu et al. The Lancet Healthy Longevity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fude Yang China	12	149	96	57	55	51	28	391
Sang Jin Rhee South Korea	13	141 0.9×	131 1.4×	81 1.4×	45 0.8×	43 0.8×	57	514
Niko Seppälä Finland	12	251 1.7×	89 0.9×	55 1.0×	53 1.0×	16 0.3×	20	398
Hsin Chun Tsai Taiwan	12	115 0.8×	41 0.4×	42 0.7×	41 0.7×	51 1.0×	21	320
Sjors M. M. Lange Netherlands	4	154 1.0×	103 1.1×	50 0.9×	24 0.4×	21 0.4×	5	389
Maxime Barakat Canada	8	103 0.7×	109 1.1×	29 0.5×	207 3.8×	64 1.3×	19	455
Carla Conroy United States	14	404 2.7×	132 1.4×	46 0.8×	111 2.0×	37 0.7×	30	624
Szu‐Nian Yang Taiwan	10	65 0.4×	50 0.5×	31 0.5×	37 0.7×	33 0.6×	22	415
Simone Bolognesi Italy	12	98 0.7×	66 0.7×	40 0.7×	46 0.8×	46 0.9×	34	380
Christopher L. Sola United States	12	153 1.0×	116 1.2×	34 0.6×	162 2.9×	51 1.0×	23	619
Alexander Maget Austria	10	195 1.3×	171 1.8×	93 1.6×	17 0.3×	40 0.8×	35	386

Countries citing papers authored by Fude Yang

Since Specialization

Citations

This map shows the geographic impact of Fude Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fude Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fude Yang more than expected).

Fields of papers citing papers by Fude Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fude Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fude Yang. The network helps show where Fude Yang may publish in the future.

Co-authorship network of co-authors of Fude Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Fude Yang. A scholar is included among the top collaborators of Fude Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fude Yang. Fude Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Fude, et al.. (2025). Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology. 15. 1967259940–1967259940.

Gram, Lu, Fude Yang, Donghua Mi, et al.. (2025). Health inequalities in disease burden of dementia and early-onset dementia: findings from the Global Burden of Disease 2021 study. Global Health Research and Policy. 10(1). 21–21.

Zhang, Zhihong, Xuxia Liu, Zhengjun Chen, et al.. (2024). Integrated network pharmacology, transcriptomics and metabolomics to explore the material basis and mechanism of Danggui-Baishao herb pair for treating hepatic fibrosis. Journal of Ethnopharmacology. 337(Pt 1). 118834–118834. 3 indexed citations

Wang, Yaping, Min Liu, Fude Yang, et al.. (2024). The associations of socioeconomic status, social activities, and loneliness with depressive symptoms in adults aged 50 years and older across 24 countries: findings from five prospective cohort studies. The Lancet Healthy Longevity. 5(9). 100618–100618. 35 indexed citations breakdown →

Gao, Peng, Guiying Cao, Jue Liu, Fude Yang, & Min Liu. (2023). Global, regional, and national trends in incidence of depression among women, 1990-2019: An analysis of the global burden of disease study. Psychiatry Research. 331. 115668–115668. 9 indexed citations

Zhang, Ping, Yanli Li, Kesheng Wang, et al.. (2022). Altered DNA methylation of CYP2E1 gene in schizophrenia patients with tardive dyskinesia. BMC Medical Genomics. 15(1). 253–253. 6 indexed citations

Li, Na, Yanli Li, Junchao Huang, et al.. (2022). Dysfunctional monocytic toll-like receptor 4 signaling pathway and cognitive deficits in chronic schizophrenia patients with tardive dyskinesia. Neuroscience Letters. 777. 136581–136581. 7 indexed citations

Su, Yun‐Ai, Fude Yang, Gang Wang, et al.. (2022). Prevalence, clinical features and prescription patterns of psychotropic medications for patients with psychotic depression in China. Journal of Affective Disorders. 301. 248–252. 6 indexed citations

Liu, Yanhong, et al.. (2022). Association between changes in the retina with major depressive disorder and sleep quality. Journal of Affective Disorders. 311. 548–553. 10 indexed citations

10.

Zhang, Ping, Junchao Huang, Yanfang Zhou, et al.. (2021). Kynurenine metabolism and metabolic syndrome in patients with schizophrenia. Journal of Psychiatric Research. 139. 54–61. 10 indexed citations

11.

Ma, Qiuyue, Fude Yang, Wenzhan Jing, et al.. (2021). Prevalence of nonalcoholic fatty liver disease in mental disorder inpatients in China: an observational study. Hepatology International. 15(1). 127–136. 20 indexed citations

12.

Ma, Ruihua, Nan Chen, Hua Guo, et al.. (2021). Differences in Facial Expression Recognition Between Unipolar and Bipolar Depression. Frontiers in Psychology. 12. 619368–619368. 11 indexed citations

13.

Mi, Weifeng, Fude Yang, Huafang Li, et al.. (2021). Efficacy, Safety, and Tolerability of Ansofaxine (LY03005) Extended-Release Tablet for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Clinical Trial. The International Journal of Neuropsychopharmacology. 25(3). 252–260. 16 indexed citations

14.

Zhu, Yubing, Weidong Wu, Qi Zhang, et al.. (2021). A correlation study of intestinal microflora and first‐episode depression in Chinese patients and healthy volunteers. Brain and Behavior. 11(8). e02036–e02036. 40 indexed citations

15.

Yang, Fude, Qiuyue Ma, Jue Liu, et al.. (2020). Prevalence and major risk factors of type 2 diabetes mellitus among adult psychiatric inpatients from 2005 to 2018 in Beijing, China: a longitudinal observational study. BMJ Open Diabetes Research & Care. 8(1). e000996–e000996. 10 indexed citations

16.

Chen, Lin, Yun‐Ai Su, Fude Yang, et al.. (2018). Prevalence and clinical features of atypical depression among patients with major depressive disorder in China. Journal of Affective Disorders. 246. 285–289. 14 indexed citations

17.

Lin, Jingyu, Yun‐Ai Su, Chunxia Wang, et al.. (2018). Effects of tandospirone augmentation in major depressive disorder patients with high anxiety: A multicenter, randomized, parallel-controlled, open-label study. Journal of Psychiatric Research. 99. 104–110. 21 indexed citations

18.

Si, Tianmei, Gang Wang, Fude Yang, et al.. (2017). Efficacy and safety of escitalopram in treatment of severe depression in Chinese population. Metabolic Brain Disease. 32(3). 891–901. 16 indexed citations

19.

Liu, Haibo, Yimin Kang, Jun Liang, et al.. (2012). Lower serum interleukin-2 levels in schizophrenic patients with tardive dyskinesia. Psychiatry Research. 198(2). 329–331. 21 indexed citations

20.

Wang, Fan, Hongzhen Fan, Fude Yang, et al.. (2011). Association between TNF-α promoter −308A/G polymorphism and tardive dyskinesiain Chinese Han patients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 37(1). 106–110. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact